Renal and hemodynamic effects of isradipine in essential hypertension
- 17 April 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 86 (4) , 60-64
- https://doi.org/10.1016/0002-9343(89)90192-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Calcium Antagonists and Neural Control of Circulation in Essential HypertensionJournal Of Hypertension, 1987
- Nifedipine, Diuretics and Sodium BalanceJournal Of Hypertension, 1987
- Treatment of essential hypertension with PN 200-110 (isradipine)The American Journal of Cardiology, 1987
- Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.Journal of Clinical Investigation, 1985
- Natriuretic Effect of Calcium AntagonistsJournal of Cardiovascular Pharmacology, 1985
- Separation of the Coronary Vasodilator from the Cardiac Effects of PN 200–110, a New Dihydropyridine Calcium Antagonist, in the Dog HeartJournal of Cardiovascular Pharmacology, 1985
- Effects of the New Calcium Antagonist PN 200–110 on the Myocardium and the Regional Peripheral Circulation in Anesthetized Cats and DogsJournal of Cardiovascular Pharmacology, 1984
- Effects of Verapamil in Hypertensive PatientsActa Medica Scandinavica, 1984
- Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic methodLife Sciences, 1979
- Plasma Renin Concentration Measured by Use of Radioimmunoassay for Angiotensin IScandinavian Journal of Clinical and Laboratory Investigation, 1970